These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21879987)

  • 41. Effect of alpha-phenyl-tert-butylnitrone on endotoxin toxemia in horses.
    Harkins JD; Carney JM; Meier M; Leak SC; Tobin T
    Vet Hum Toxicol; 1997 Oct; 39(5):268-71. PubMed ID: 9311081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survey of diplomates of the American College of Veterinary Internal Medicine and the American College of Veterinary Surgeons regarding clinical aspects and treatment of endotoxemia in horses.
    Shuster R; Traub-Dargatz J; Baxter G
    J Am Vet Med Assoc; 1997 Jan; 210(1):87-92. PubMed ID: 8977655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of an intravenous endotoxin challenge on glucose and insulin dynamics in horses.
    Tóth F; Frank N; Elliott SB; Geor RJ; Boston RC
    Am J Vet Res; 2008 Jan; 69(1):82-8. PubMed ID: 18167091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-inflammatory and analgesic effects of intra-articular injection of triamcinolone acetonide, mepivacaine hydrochloride, or both on lipopolysaccharide-induced lameness in horses.
    Kay AT; Bolt DM; Ishihara A; Rajala-Schultz PJ; Bertone AL
    Am J Vet Res; 2008 Dec; 69(12):1646-54. PubMed ID: 19046013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of early-phase endotoxin tolerance in horses.
    Allen GK; Campbell-Beggs C; Robinson JA; Johnson PJ; Green EM
    Equine Vet J; 1996 Jul; 28(4):269-74. PubMed ID: 8818592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperleptinemia in horses: responses to administration of a small dose of lipopolysaccharide endotoxin in mares and geldings.
    Huff NK; Thompson DL; Mitcham PB; Storer WA
    J Anim Sci; 2010 Mar; 88(3):926-36. PubMed ID: 19966166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.
    Menzies-Gow NJ; Sepulveda MF; Bailey SR; Cunningham FM; Elliott J
    Am J Vet Res; 2008 Feb; 69(2):199-207. PubMed ID: 18241016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in serum parathyroid hormone and electrolyte concentrations and urinary excretion of electrolytes in horses with induced endotoxemia.
    Toribio RE; Kohn CW; Hardy J; Rosol TJ
    J Vet Intern Med; 2005; 19(2):223-31. PubMed ID: 15822568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of duodenal glucose infusion on blood glucose concentration in endotoxin-treated calves.
    Bieniek K
    Zentralbl Veterinarmed A; 1998 Oct; 45(8):481-90. PubMed ID: 9838860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes.
    Figueiredo MD; Moore JN; Vandenplas ML; Sun WC; Murray TF
    Am J Vet Res; 2008 Jun; 69(6):796-803. PubMed ID: 18518661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of hypertonic vs isotonic saline solution on responses to sublethal Escherichia coli endotoxemia in horses.
    Bertone JJ; Gossett KA; Shoemaker KE; Bertone AL; Schneiter HL
    Am J Vet Res; 1990 Jul; 51(7):999-1007. PubMed ID: 2202242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of hyperglycemia and endotoxemia on coagulation parameters in healthy adult horses.
    McGovern KF; Lascola KM; Smith SA; Clark-Price SC; Wilkins PA; Schaeffer DJ; Foreman JH
    J Vet Intern Med; 2013; 27(2):347-53. PubMed ID: 23480666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Respiratory, renal, hematologic, and serum biochemical effects of hypertonic saline solution in endotoxemic calves.
    Constable PD; Schmall LM; Muir WW; Hoffsis GF
    Am J Vet Res; 1991 Jul; 52(7):990-8. PubMed ID: 1892279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production.
    Li F; Fang L; Huang S; Yang Z; Nandi J; Thomas S; Chen C; Camporesi E
    Anesth Analg; 2011 Sep; 113(3):626-33. PubMed ID: 21596875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor necrosis factor activity in the circulation of horses given endotoxin.
    MacKay RJ; Merritt AM; Zertuche JM; Whittington M; Skelley LA
    Am J Vet Res; 1991 Apr; 52(4):533-8. PubMed ID: 2053720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Digital blood flow and plasma endothelin concentration in clinically endotoxemic horses.
    Menzies-Gow NJ; Bailey SR; Stevens K; Katz L; Elliott J; Marr CM
    Am J Vet Res; 2005 Apr; 66(4):630-6. PubMed ID: 15900943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of amrinone on tissue oxygenation of jejunal mucosa during endotoxemia.
    Schmidt W; Tinelli M; Walther A; Gebhard MM; Martin E; Schmidt H
    J Surg Res; 2000 Sep; 93(1):9-15. PubMed ID: 10945937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rac1 mediates sex difference in cardiac tumor necrosis factor-alpha expression via NADPH oxidase-ERK1/2/p38 MAPK pathway in endotoxemia.
    Zhu H; Shan L; Peng T
    J Mol Cell Cardiol; 2009 Aug; 47(2):264-74. PubMed ID: 19450605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma leptin responses to lipopolysaccharide and tumor necrosis factor alpha in cows.
    Soliman M; Ishioka K; Kimura K; Kushibiki S; Saito M
    Jpn J Vet Res; 2002 Nov; 50(2-3):107-14. PubMed ID: 12619302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Norepinephrine and vasopressin counteract anti-inflammatory effects of isoflurane in endotoxemic rats.
    Hofstetter C; Boost KA; Hoegl S; Flondor M; Scheller B; Muhl H; Pfeilschifter J; Zwissler B
    Int J Mol Med; 2007 Oct; 20(4):597-604. PubMed ID: 17786293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.